Myovant Sciences (MYOV) Stock Highlights

26.98 | -0.04%

2023-04-13 17:31:15

Myovant Sciences Ltd is a healthcare company focused on redefining care for women and for men. The companys lead product candidate is relugolix, a once-daily, oral GnRH receptor antagonist. It has three late-stage clinical programs for relugolix in uterine fibroids, endometriosis, and prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, that has completed a Phase 2a study for the treatment of female infertility as part of assisted reproduction.

Statistics

Range Today

26.98 27

Volume Today 2.21M

Range 1 Year

7.67 27.06

Volume 1 Year 271.76M

Range 3 Year

5.98 30.9

Volume 3 Year 738.78M

Range 10 Year

4.14 30.9

Volume 10 Year 1.02B

Highlights

Market Capitalization 2.62B (mid)

Floating Shares 50.86M

Current Price 26.98

Price To Earnings -14.06

Price To Revenue 7.16

Earnings Per Share -1.92

Payout Ratio 0%

Performance

Latest -0.04%

1 Month +0.22%

3 Months +0.48%

6 Months +36.06%

1 Year +123.34%

3 Years +166.6%

5 Years +63.81%

10 Years +79.87%

Benchmarks

Market Capitalization

68 / 368

Gross Profits

54 / 278

Total Revenue

29 / 300

Total Rank

338 / 368

Free Cashflow

314 / 352

Performance 5 years

87 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.